Compare NTSK & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTSK | MIR |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | 3281 | 3281 |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.6B |
| IPO Year | N/A | N/A |
| Metric | NTSK | MIR |
|---|---|---|
| Price | $12.32 | $17.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | $18.19 | ★ $27.25 |
| AVG Volume (30 Days) | ★ 6.5M | 4.0M |
| Earning Date | 03-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.76 | $23.95 |
| Revenue Next Year | $22.02 | $7.32 |
| P/E Ratio | ★ N/A | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.67 | $15.58 |
| 52 Week High | $24.98 | $30.28 |
| Indicator | NTSK | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 67.77 | 45.88 |
| Support Level | $10.61 | $16.49 |
| Resistance Level | $13.06 | $20.29 |
| Average True Range (ATR) | 0.73 | 0.84 |
| MACD | 0.28 | -0.10 |
| Stochastic Oscillator | 93.43 | 35.77 |
Netskope Inc is redefining the security and networking of cloud and AI. The company has formed a cloud-native platform that offers converged security, networking services, and analytics technology stack to enable fast and secure AI, cloud, and web access at the edge. The products of the company include Netskope One SASE, Netskope One SSE, Cloud Access Security Broker (CASB), Next Generation Secure Web Gateway (SWG), Private Access, Cloud Firewall, SD-WAN, SkopeAI, and others.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.